The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.Product was used for therapeutic treatment.The preoperative and postoperative diagnosis was pelvic pain.The procedure performed was a removal of prior sacrocolpopexy and placement of a new sacrocolpopexy mesh.The patient underwent an additional procedure on (b)(6) 2016.The preoperative and postoperative diagnosis was stress urinary incontinence.The procedure performed was a cystoscopy with regular transvaginal tape sling.At this time a gynecare tvt was implanted.The patient has experienced incontinence, blood loss, prolapse, pain, itching, shaking, fibrosis, inflammation, fragments of mesh, additional surgical interventions.New information indicates patient is deceased.The death certificate indicates the immediate cause breast cancer, neutropenia, septic shock and multiorgan failure (natural causes is checked on the death certificate).There was no indication that a bard product contributed to her death.
|